Home/Filings/4/0001209191-20-017393
4//SEC Filing

White Barbara 4

Accession 0001209191-20-017393

CIK 0001595097other

Filed

Mar 8, 8:00 PM ET

Accepted

Mar 9, 5:22 PM ET

Size

5.6 KB

Accession

0001209191-20-017393

Insider Transaction Report

Form 4
Period: 2020-03-06
White Barbara
Chief Medical Officer
Transactions
  • Award

    Stock Option(right to buy)

    2020-03-06+226,000226,000 total
    Exercise: $4.53Exp: 2030-03-06Common Stock (226,000 underlying)
Footnotes (1)
  • [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 6, 2021, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 6, 2021.

Issuer

Corbus Pharmaceuticals Holdings, Inc.

CIK 0001595097

Entity typeother

Related Parties

1
  • filerCIK 0001625844

Filing Metadata

Form type
4
Filed
Mar 8, 8:00 PM ET
Accepted
Mar 9, 5:22 PM ET
Size
5.6 KB